Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOTAM study of therapeutic drug monitoring-guided tamoxifen dosing
NL-OMON23682Recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tamoxifen in breast cancer, sponsored by Erasmus MC. Primary endpoint: Feasibility of therapeutic drug monitoring of tamoxifen in clinical practice. Started Jan 2018; status: recruiting.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON23682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23682.